Concepedia

Kathy Collier

KC

Statistics

Publications

1

Citations

670

H-Index

1

Active since

1989

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kathy Collier is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in macrolide therapy, immunology, and signal transduction.

Publications per year

1989–1989

1

Publications

1

The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

Michael J. Tocci, D A Matkovich, Kathy Collier et al. · The Journal of Immunology · 1989 · 670 citations

, , +16

1–1 of 1